Targeted Therapies - EGFR

You are here

Targeted Therapies - EGFR

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

ASCO Lung Cancer Roundtable - NSCLC - The SINDAS Trial: Addition of SBRT to a Systemic TKI for EGFR
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Radiation Therapy, Non Small Cell Lung Cancer
ASCO Lung Cancer Roundtable - Trial Updates in NSCLC - ADAURA Trial and Post Surgery EGFR Mutation
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Adjuvant Therapy, Targeted Therapies - EGFR, Non Small Cell Lung Cancer
ASCO 2018 - Combining Metformin with Standard EGFR Therapy - Is the Jury Still Out
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Chemotherapy, Non Small Cell Lung Cancer, Targeted Therapies - EGFR
ASCO 2018 - Tarceva or Tarceva with Avastin as 1st Line for EGFR Positive NSCLC vs. Tagrisso or Vizimpro
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Targeted Therapies - EGFR, First-line treatment
Lung Cancer Video Library - 2017 The Changing Landscape of First Line Treatment for EGFR Mutation-Positive NSCLC
Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses the changing landscape of first-line treatment for EGFR mutation-positive non-small cell lung cancer (NSCLC).
Cancer Journey:
Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
First-line treatment, Targeted Therapies - EGFR

Articles

Registration is Now Open for the 2019 Targeted Therapies Live Patient Forum
Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...
Cancer Journey:
Just Diagnosed, In Treatment, In Remission, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1
Direct Comparison of 2 EGFR Inhibitors Shows There Are Clinically Significant Differences
Fast forward 1.5 years, and we now have the early results of LUX-Lung-7, and they show that these EGFR TKIs are not completely interchangeable...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, First-line treatment, Targeted Therapies - EGFR

Community Forum

9/12/2020 online Targeted Therapies Patient Forum
The Targeted Therapies Patient Forum from CancerGrace.org is finally here and FREE to anyone. Originally scheduled for earlier this year our forum is...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Targeted Therapy, Molecular Testing, First-line treatment, Non Small Cell Lung Cancer, Targeted Therapies Blood
Targeted Therapies Patient Forum in Boston
MARCH 28, PUT IN ON YOUR CALENDARS. I always learn so much at the live patient forums even attending them virtually. Our faculty is outstanding in...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Non Small Cell Lung Cancer
Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?
Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Drugs, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Procedures & Treatments, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Investigational Agents, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Progression on Tarceva - T790m negative
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Molecular Testing, Immunotherapies, Non Small Cell Lung Cancer
Can Tagrisso be used in additional to Alimta maintenance
My wife was on Tarceva for over 6 1/2 years. Then she developed acquired resistance to Tarceva with prevascular and supraclevical lymph nodes...
Cancer Journey:
Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies - EGFR, Biopsy/Tissue Collection, Maintenance Therapy, Non Small Cell Lung Cancer